WC
Weaver Consulting Group
13F filer · CIK 0001780055Reported Jul 29, 2026
Net buyer this quarter
13F portfolio value$488MU.S. long equity reported on 13F
Positions11614 new · 8 closed
Net flow last quarter+$15.8MBuys minus sells
Top 10 positions weight12.2%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Jul 29, 2026116 positions | |||||
| $14.3M | 2.94% | 0.00% | +162.4% | Q1 2019 | |
| $11.1M | 2.28% | 0.00% | +0.6% | Q1 2019 | |
| $5.96M | 1.22% | 0.00% | +1.8% | Q1 2019 | |
| $4.65M | 0.95% | 0.00% | +13.1% | Q1 2019 | |
| $4.42M | 0.91% | Not reported | +2.5% | Q1 2019 | |
| $4.3M | 0.88% | 0.00% | +7.2% | Q1 2019 | |
| $4.25M | 0.87% | 0.01% | -0.5% | Q1 2019 | |
| $3.95M | 0.81% | 0.00% | +3.9% | Q1 2019 | |
| $3.7M | 0.76% | 0.00% | +2.2% | Q1 2019 | |
| $2.66M | 0.55% | Not reported | -0.2% | Q1 2023 | |
| $2.57M | 0.53% | 0.00% | +1503.9% | Q3 2025 | |
| $2.57M | 0.53% | Not reported | +0.5% | Q1 2019 | |
| $2.53M | 0.52% | Not reported | -0.2% | Q1 2019 | |
| $2.49M | 0.51% | Not reported | -4.7% | Q1 2019 | |
| $2.39M | 0.49% | 0.01% | -0.8% | Q2 2019 | |
| $1.63M | 0.34% | 0.00% | +2.4% | Q3 2021 | |
| $1.61M | 0.33% | 0.00% | +2.0% | Q2 2024 | |
| $1.57M | 0.32% | 0.00% | +24.2% | Q1 2019 | |
| $1.46M | 0.30% | 0.00% | +4.7% | Q1 2019 | |
| $1.44M | 0.29% | Not reported | -0.4% | Q1 2020 | |
| $1.43M | 0.29% | 0.00% | +17.5% | Q1 2019 | |
| $1.4M | 0.29% | Not reported | -0.6% | Q1 2019 | |
| $1.39M | 0.28% | 0.00% | +21.0% | Q1 2019 | |
| $1.37M | 0.28% | 0.00% | +0.1% | Q1 2019 | |
| $1.27M | 0.26% | 0.00% | -0.7% | Q1 2019 | |
| $1.07M | 0.22% | 0.00% | -0.1% | Q1 2019 | |
| $1.07M | 0.22% | Not reported | -2.0% | Q1 2019 | |
| $1.07M | 0.22% | 0.00% | +0.5% | Q1 2019 | |
| $1.06M | 0.22% | 0.00% | -1.0% | Q1 2019 | |
| $1.06M | 0.22% | 0.00% | +19.8% | Q1 2019 | |
| $1.05M | 0.22% | 0.00% | -6.2% | Q1 2019 | |
| $1M | 0.21% | 0.01% | Not reported | Q1 2025 | |
| $936K | 0.19% | 0.00% | -6.4% | Q1 2019 | |
| $913K | 0.19% | 0.00% | -0.2% | Q1 2019 | |
| $899K | 0.18% | 0.00% | -1.8% | Q1 2020 | |
| $890K | 0.18% | 0.00% | -10.2% | Q1 2019 | |
| $844K | 0.17% | 0.00% | +111.2% | Q1 2019 | |
| $810K | 0.17% | 0.00% | +0.6% | Q1 2019 | |
| $768K | 0.16% | 0.00% | Not reported | Q1 2019 | |
| $731K | 0.15% | 0.00% | +0.1% | Q1 2019 | |
| $717K | 0.15% | 0.00% | +1.0% | Q1 2019 | |
| $710K | 0.15% | Not reported | Not reported | Q1 2019 | |
| $703K | 0.14% | 0.00% | +0.7% | Q1 2019 | |
| $661K | 0.14% | 0.00% | +6.4% | Q1 2019 | |
| $641K | 0.13% | 0.00% | -4.9% | Q1 2019 | |
| $633K | 0.13% | 0.00% | -11.3% | Q1 2019 | |
| PBPMBSPuramed Bioscience Inc. | $628K | 0.13% | 0.01% | -1.6% | Q4 2024 |
| $626K | 0.13% | 0.00% | -1.4% | Q1 2019 | |
| $617K | 0.13% | 0.00% | -0.6% | Q1 2019 | |
| $592K | 0.12% | 0.00% | -23.6% | Q2 2024 | |
| Q1 2026Reported May 15, 2026110 positions | |||||
| $9.68M | 2.31% | 0.00% | -1.6% | Q1 2019 | |
| $5.81M | 1.39% | 0.00% | +1.0% | Q1 2019 | |
| $4.77M | 1.14% | 0.00% | -0.3% | Q1 2019 | |
| $4.22M | 1.01% | 0.00% | -0.9% | Q1 2019 | |
| $3.78M | 0.90% | 0.01% | -0.7% | Q1 2019 | |
| $3.75M | 0.89% | Not reported | Not reported | Q1 2019 | |
| $3.5M | 0.84% | 0.00% | +4.8% | Q1 2019 | |
| $3.5M | 0.83% | 0.00% | -1.1% | Q1 2019 | |
| $3.31M | 0.79% | 0.00% | +0.3% | Q1 2019 | |
| $2.5M | 0.60% | Not reported | +12.5% | Q1 2019 | |
| $2.47M | 0.59% | Not reported | +5.6% | Q1 2023 | |
| $2.37M | 0.57% | Not reported | -6.9% | Q1 2019 | |
| $2.29M | 0.55% | 0.02% | -0.6% | Q2 2019 | |
| $2M | 0.48% | Not reported | -1.9% | Q1 2019 | |
| $1.57M | 0.37% | 0.00% | +1.5% | Q1 2019 | |
| $1.45M | 0.35% | 0.00% | +0.1% | Q1 2019 | |
| $1.43M | 0.34% | 0.00% | +0.7% | Q1 2019 | |
| $1.43M | 0.34% | Not reported | +4.1% | Q1 2019 | |
| $1.33M | 0.32% | 0.00% | Not reported | Q1 2019 | |
| $1.3M | 0.31% | Not reported | -5.4% | Q1 2020 | |
| $1.24M | 0.29% | 0.00% | +2.1% | Q1 2019 | |
| $1.23M | 0.29% | 0.00% | -1.2% | Q1 2019 | |
| $1.21M | 0.29% | 0.00% | -0.1% | Q3 2021 | |
| $1.17M | 0.28% | 0.00% | +0.1% | Q2 2024 | |
| $1.17M | 0.28% | 0.00% | -2.4% | Q1 2019 | |
| $1.09M | 0.26% | 0.00% | +0.1% | Q1 2019 | |
| $997K | 0.24% | 0.00% | -3.5% | Q1 2019 | |
| $988K | 0.24% | 0.00% | +0.6% | Q1 2019 | |
| $963K | 0.23% | 0.00% | -1.0% | Q1 2019 | |
| $939K | 0.22% | 0.01% | -8.2% | Q1 2025 | |
| $930K | 0.22% | 0.00% | +0.2% | Q1 2020 | |
| $883K | 0.21% | Not reported | +2.3% | Q1 2019 | |
| $743K | 0.18% | 0.00% | Not reported | Q1 2019 | |
| $743K | 0.18% | 0.00% | 0.0% | Q1 2019 | |
| $720K | 0.17% | 0.00% | -0.9% | Q1 2019 | |
| PBPMBSPuramed Bioscience Inc. | $640K | 0.15% | 0.01% | Not reported | Q4 2024 |
| $629K | 0.15% | Not reported | -0.5% | Q1 2019 | |
| $616K | 0.15% | 0.00% | -2.7% | Q1 2019 | |
| $612K | 0.15% | 0.00% | +3.1% | Q1 2019 | |
| $599K | 0.14% | 0.00% | +0.1% | Q1 2019 | |
| $598K | 0.14% | 0.00% | +0.9% | Q1 2019 | |
| $575K | 0.14% | 0.00% | +0.7% | Q1 2019 | |
| $551K | 0.13% | 0.00% | +0.2% | Q1 2025 | |
| $543K | 0.13% | 0.00% | -2.1% | Q1 2019 | |
| $531K | 0.13% | 0.00% | -1.7% | Q1 2019 | |
| $525K | 0.13% | 0.00% | -1.3% | Q1 2019 | |
| $492K | 0.12% | 0.00% | -15.0% | Q1 2019 | |
| $486K | 0.12% | Not reported | Not reported | Q1 2019 | |
| $481K | 0.11% | 0.02% | +40.3% | Q4 2024 | |
| $479K | 0.11% | 0.00% | Not reported | Q1 2019 | |
| Q4 2025Reported Feb 10, 2026109 positions | |||||
| $10.5M | 2.58% | 0.00% | +4.5% | Q1 2019 | |
| $7.52M | 1.84% | 0.00% | +0.9% | Q1 2019 | |
| $5.11M | 1.25% | 0.00% | -0.2% | Q1 2019 | |
| $4.06M | 0.99% | 0.01% | +2.6% | Q1 2019 | |
| $3.94M | 0.96% | Not reported | +0.6% | Q1 2019 | |
| $3.92M | 0.96% | 0.00% | -1.5% | Q1 2019 | |
| $3.86M | 0.94% | 0.00% | -1.0% | Q1 2019 | |
| $3.71M | 0.91% | 0.00% | +0.6% | Q1 2019 | |
| $3.59M | 0.88% | 0.00% | +1.1% | Q1 2019 | |
| $2.47M | 0.60% | Not reported | +1.3% | Q1 2019 | |
| $2.39M | 0.58% | Not reported | +1.0% | Q1 2023 | |
| $2.33M | 0.57% | Not reported | +0.1% | Q1 2019 | |
| $2.18M | 0.53% | 0.02% | -0.8% | Q2 2019 | |
| $2.17M | 0.53% | Not reported | -0.2% | Q1 2019 | |
| $1.59M | 0.39% | Not reported | +0.9% | Q1 2019 | |
| $1.46M | 0.36% | 0.00% | +2.9% | Q1 2019 | |
| $1.42M | 0.35% | Not reported | +67.5% | Q1 2020 | |
| $1.32M | 0.32% | 0.00% | -0.1% | Q3 2021 | |
| $1.26M | 0.31% | 0.00% | +1.0% | Q1 2019 | |
| $1.15M | 0.28% | 0.00% | +0.7% | Q1 2019 | |
| $1.1M | 0.27% | 0.00% | +0.3% | Q1 2019 | |
| $1.07M | 0.26% | 0.00% | -1.0% | Q1 2019 | |
| $1.07M | 0.26% | 0.00% | +0.7% | Q1 2019 | |
| $1.06M | 0.26% | 0.00% | -0.6% | Q1 2019 | |
| $1.05M | 0.26% | 0.00% | +0.3% | Q1 2019 | |
| $1.03M | 0.25% | 0.01% | +13.9% | Q1 2025 | |
| $1.03M | 0.25% | 0.00% | +1.0% | Q1 2019 | |
| $944K | 0.23% | Not reported | +2.8% | Q1 2019 | |
| $888K | 0.22% | 0.00% | +0.6% | Q1 2019 | |
| $883K | 0.22% | 0.00% | +0.7% | Q1 2020 | |
| $880K | 0.22% | 0.00% | -4.8% | Q1 2019 | |
| $875K | 0.21% | 0.00% | +0.1% | Q2 2024 | |
| $738K | 0.18% | 0.00% | -3.7% | Q1 2019 | |
| $725K | 0.18% | 0.00% | +0.1% | Q1 2019 | |
| $694K | 0.17% | 0.00% | 0.0% | Q1 2019 | |
| $674K | 0.16% | 0.00% | -10.9% | Q1 2019 | |
| $656K | 0.16% | Not reported | Not reported | Q1 2019 | |
| PBPMBSPuramed Bioscience Inc. | $642K | 0.16% | 0.01% | Not reported | Q4 2024 |
| $618K | 0.15% | 0.00% | +0.2% | Q1 2019 | |
| $591K | 0.14% | 0.00% | Not reported | Q1 2025 | |
| $589K | 0.14% | 0.00% | +6.1% | Q1 2019 | |
| $577K | 0.14% | 0.00% | +1.9% | Q1 2019 | |
| $565K | 0.14% | 0.00% | Not reported | Q1 2019 | |
| $562K | 0.14% | 0.00% | +2.7% | Q1 2019 | |
| $537K | 0.13% | 0.00% | -0.1% | Q1 2019 | |
| $533K | 0.13% | 0.00% | -0.8% | Q1 2019 | |
| $522K | 0.13% | 0.00% | +2.3% | Q1 2019 | |
| $513K | 0.13% | Not reported | Not reported | Q1 2019 | |
| $472K | 0.12% | 0.00% | -1.7% | Q3 2025 | |
| $459K | 0.11% | 0.00% | +3.9% | Q1 2019 | |
| Q3 2025Reported Nov 12, 2025108 positions | |||||
| $9.45M | 2.40% | 0.00% | Not reported | Q1 2019 | |
| $7.98M | 2.03% | 0.00% | Not reported | Q1 2019 | |
| $5.12M | 1.30% | 0.00% | Not reported | Q1 2019 | |
| $3.88M | 0.99% | 0.00% | Not reported | Q1 2019 | |
| $3.82M | 0.97% | Not reported | Not reported | Q1 2019 | |
| $3.61M | 0.92% | 0.01% | Not reported | Q1 2019 | |
| $3.57M | 0.91% | 0.00% | Not reported | Q1 2019 | |
| $3.51M | 0.89% | 0.00% | Not reported | Q1 2019 | |
| $2.76M | 0.70% | 0.00% | Not reported | Q1 2019 | |
| $2.4M | 0.61% | Not reported | Not reported | Q1 2019 | |
| $2.33M | 0.59% | Not reported | Not reported | Q1 2019 | |
| $2.31M | 0.59% | 0.02% | Not reported | Q2 2019 | |
| $2.29M | 0.58% | Not reported | Not reported | Q1 2023 | |
| $2.12M | 0.54% | Not reported | Not reported | Q1 2019 | |
| $1.75M | 0.44% | Not reported | Not reported | Q1 2019 | |
| $1.41M | 0.36% | 0.00% | Not reported | Q1 2019 | |
| $1.34M | 0.34% | 0.00% | Not reported | Q1 2019 | |
| $1.29M | 0.33% | 0.00% | Not reported | Q3 2021 | |
| $1.2M | 0.30% | 0.00% | Not reported | Q1 2019 | |
| $1.09M | 0.28% | 0.00% | Not reported | Q1 2019 | |
| $1.07M | 0.27% | 0.00% | Not reported | Q1 2019 | |
| $1.04M | 0.26% | 0.00% | Not reported | Q1 2019 | |
| $1.02M | 0.26% | 0.00% | Not reported | Q1 2019 | |
| $1M | 0.26% | 0.00% | Not reported | Q1 2019 | |
| $997K | 0.25% | 0.00% | Not reported | Q1 2019 | |
| $953K | 0.24% | 0.00% | Not reported | Q1 2019 | |
| $888K | 0.23% | 0.01% | Not reported | Q1 2025 | |
| $831K | 0.21% | Not reported | Not reported | Q1 2020 | |
| $823K | 0.21% | 0.00% | Not reported | Q2 2024 | |
| $800K | 0.20% | 0.00% | Not reported | Q1 2020 | |
| $793K | 0.20% | 0.00% | Not reported | Q1 2019 | |
| $761K | 0.19% | 0.00% | Not reported | Q1 2019 | |
| $736K | 0.19% | 0.00% | Not reported | Q1 2019 | |
| $712K | 0.18% | Not reported | Not reported | Q1 2019 | |
| $690K | 0.18% | 0.00% | Not reported | Q1 2019 | |
| $680K | 0.17% | 0.00% | Not reported | Q1 2019 | |
| PBPMBSPuramed Bioscience Inc. | $641K | 0.16% | 0.01% | Not reported | Q4 2024 |
| $633K | 0.16% | Not reported | Not reported | Q1 2019 | |
| $632K | 0.16% | 0.00% | Not reported | Q1 2019 | |
| $632K | 0.16% | 0.00% | Not reported | Q1 2019 | |
| $624K | 0.16% | 0.00% | Not reported | Q1 2019 | |
| $597K | 0.15% | Not reported | New | Q3 2025 | |
| $592K | 0.15% | 0.00% | Not reported | Q1 2019 | |
| $547K | 0.14% | 0.00% | Not reported | Q1 2025 | |
| $522K | 0.13% | 0.00% | Not reported | Q1 2019 | |
| $504K | 0.13% | 0.00% | Not reported | Q1 2019 | |
| $499K | 0.13% | Not reported | Not reported | Q1 2019 | |
| $495K | 0.13% | 0.00% | Not reported | Q1 2019 | |
| $479K | 0.12% | 0.00% | Not reported | Q1 2019 | |
| $462K | 0.12% | 0.00% | Not reported | Q1 2019 | |
Premium opens every quarter this fund has filed